NVP-TAE 684
NVP-TAE 684 (TAE 684) is a highly potent and selective ALK inhibitor, which blocks the growth of ALCL-derived and ALK-dependent cell lines with IC50 values between 2 and 10 nM[1].
Product Specifications
CAS Number
761439-42-3
Product Name Alternative
TAE 684
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Anaplastic lymphoma kinase (ALK) ; Apoptosis
Type
Reference compound
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/NVP-TAE-684.html
Concentration
10mM
Purity
99.70
Solubility
DMSO : 7.69 mg/mL (ultrasonic)
Smiles
O=S(C1=CC=CC=C1NC2=NC(NC3=CC=C(N4CCC(N5CCN(CC5)C)CC4)C=C3OC)=NC=C2Cl)(C(C)C)=O
Molecular Formula
C30H40ClN7O3S
Molecular Weight
614.20
Precautions
H302, H315, H319, H335
References & Citations
[1]Galkin AV, et al. Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK. Proc Natl Acad Sci U S A. 2007 Jan 2;104 (1) :270-5.|[2]Katayama R, et al. Therapeutic strategies to overcome PF-02341066 resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK. Proc Natl Acad Sci U S A. 2011 May 3;108 (18) :7535-40.|[3]Schonherr C, Activating ALK mutations found in neuroblastoma are inhibited by PF-02341066 and NVP-TAE684. Biochem J. 2011 Dec 15;440 (3) :405-13.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![EPHX2 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI3F6]](https://cdn.genprice.uk/products/937/6868c332994c49e6dc3f0e70/imageurl/ta501628am.webp)
TA501628AM 100 µL
EPHX2 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI3F6]
Sign In for Pricing
View Details 
TIT-C52H7-100ug 100 µg
Canine TIGIT Protein, His Tag (MALS verified)
Sign In for Pricing
View Details 
